General description
Enoxaparin Sodium is the sodium salt of a depolymerized heparin. It consists of a complex set of oligosaccharides that have not yet been completely characterized. Most of the components have a 4-enopyranose uronate structure at the nonreducing end of their chain. About 20% of the materials contain a 1,6-anhydro derivative on the reducing end of the chain, the range being between 15% and 25%. Enoxaparin sodium USP reference standard is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Enoxaparin sodium USP reference standard is used to prepare standard solutions for the identification of enoxaparin sodium using specific assays as described in the USP monographs. Further information is available in monograph, Enoxaparin Sodium, USP43-NF38 – 1623 of USP.
Other Notes
This product is part of the USP Biologics program and intended for use as a reference standard in pharmaceutical research and development. This product is for test and assay use only. It is not tested for animal or human consumption, clinical testing, or therapeutic use.
USP issued SDS can be found here.
Sales restrictions may apply.
- UPC:
- 51131607
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- 1235820-300MG
